Osteoporosis 2016 | Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD: Elizabeth Curtis #osteo2016
Elizabeth Curtis's presentation from Osteoporosis 2016: Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD:
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Vertebral Fracture Identification presented by Dr Andrew Pearson, Consultant Radiologist, Borders Hospital, Melrose at the fracture liaison service champions' summit 2016. #flschampions
Dr Steve Cummings presentation from Osteoporosis 2016: Patients receiving bisphosphonates should not take holidays from treatment.
Find out more at: https://nos.org.uk/conference
Dr Zoe Paskins's presentation from Osteoporosis 2016: Risk of fragility fracture over 10 years across eight inflammatory conditions: A UK population study.
Find out more at: https://nos.org.uk/conference
Dr Trevor Cole's presentation from Osteoporosis 2016: From family history to epigenetics of osteoporosis.
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Vertebral Fracture Identification presented by Dr Andrew Pearson, Consultant Radiologist, Borders Hospital, Melrose at the fracture liaison service champions' summit 2016. #flschampions
Dr Steve Cummings presentation from Osteoporosis 2016: Patients receiving bisphosphonates should not take holidays from treatment.
Find out more at: https://nos.org.uk/conference
Dr Zoe Paskins's presentation from Osteoporosis 2016: Risk of fragility fracture over 10 years across eight inflammatory conditions: A UK population study.
Find out more at: https://nos.org.uk/conference
Dr Trevor Cole's presentation from Osteoporosis 2016: From family history to epigenetics of osteoporosis.
Find out more at: https://nos.org.uk/conference
Prof. Eugene McCloskey's presentation from Osteoporosis 2016: Assessment and intervention thresholds for FRAX probabilities in the UK- Impact on the need for BMD in older women with prior fracture
Find out more at: https://nos.org.uk/conference
Presented by Linus Lay, Pharm.D. Candidate from the University of Rhode Island Class of 2022.
This presentation is on behalf of the Hackettstown Medical Center Pharmacy at Hackettstown, New Jersey as part of Continuing Education.
The Osteoporosis Overview goes over a brief introduction to osteoporosis and current/updated treatment guidelines based on global usage, drug effectiveness, and American association of clinical endocrinologists.
View MyCred Portfolio: https://mycred.com/p/2929377185
Sanni Ali's presentation from Osteoporosis 2016: Antidiabetic medication use and the risk of fracture amongst type 2 diabetic patients: a nested case-control study
Find out more at: https://nos.org.uk/conference
Dr Jennifer Walsh's presentation from Osteoporosis 2016: Management of osteoporosis in the young adult.
Find out more at: https://nos.org.uk/conference
Prof. Eugene McCloskey's presentation from Osteoporosis 2016: Assessment and intervention thresholds for FRAX probabilities in the UK- Impact on the need for BMD in older women with prior fracture
Find out more at: https://nos.org.uk/conference
Presented by Linus Lay, Pharm.D. Candidate from the University of Rhode Island Class of 2022.
This presentation is on behalf of the Hackettstown Medical Center Pharmacy at Hackettstown, New Jersey as part of Continuing Education.
The Osteoporosis Overview goes over a brief introduction to osteoporosis and current/updated treatment guidelines based on global usage, drug effectiveness, and American association of clinical endocrinologists.
View MyCred Portfolio: https://mycred.com/p/2929377185
Sanni Ali's presentation from Osteoporosis 2016: Antidiabetic medication use and the risk of fracture amongst type 2 diabetic patients: a nested case-control study
Find out more at: https://nos.org.uk/conference
Dr Jennifer Walsh's presentation from Osteoporosis 2016: Management of osteoporosis in the young adult.
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Prof. Jon Tobias's presentation from Osteoporosis 2016: Day-to-day levels of high impact physical activity are positively related to lower limb bone strength in older women: findings from a population based study using accelerometers to classify impact magnitude.
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Kate Ward's presentation from Osteoporosis 2016: Relationships between muscle function and bone microarchitecture in the Hertfordshire cohort study.
Find out more at: https://nos.org.uk/conference
Prof. Richard Eastell's presentation from Osteoporosis 2016: Patients receiving bisphosphonates should take holidays from treatment. The case for holidays.
Find out more at: https://nos.org.uk/conference
Bo Abrahamsen's presentation from Osteoporosis 2016: Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment.
Find out more at: https://nos.org.uk/conference
Prof. Nicholas Harvey's presentation from Osteoporosis 2016: Calcium, with or without vitamin D supplementation, is not associated with ischaemic heart disease or cardiac death: the UK Biobank cohort.
Find out more at: https://nos.org.uk/conference
Dr Rachel Tattersall's presentation from Osteoporosis 2016: Successful transition from paediatric to adult services.
Find out more at: https://nos.org.uk/conference
Prof. Jon Tobias's presentation from Osteoporosis 2016: What are the properties of the perfect therapy?
Find out more at: https://nos.org.uk/conference
Prof. Richard Keen's presentation from Osteoporosis 2016: Teaching old dogs new tricks? Combination therapy in osteoporosis.
Find out more at: https://nos.org.uk/conference
Sarah Chiu's presentation from Osteoporosis 2016: Impact of falls on fractures and mortality – an opportunity for intervention and enhancement of fracture prediction?
Find out more at: https://nos.org.uk/conference
Osteoporosis 2016 | Impact of falls on fractures and mortality – an opportuni...
Similar to Osteoporosis 2016 | Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD: Elizabeth Curtis #osteo2016
Adverse effects of medical treatment in the UK. Lunevicius R. Grand round, Li...Raimundas Lunevicius
1. Despite gains in reducing mortality from adverse effects (AEs) in the UK, progress has not been achieved in the reduction of incidence from AEs between 1990 and 2013
2. A direct link between deprivation level & health loss from AEs in England & the English regions is apparent, though vary, between most deprived & least deprived
3. DEPRIVATION LEVEL MATTERS on outcomes from AEs.
Dr Paramjit Gill: How inequality creates sick peoplehealth4migrants
Dr Gill's presentation on how inequality creates sick people and sick communities and why migrants particularly are at risk at the conference "Universal Healthcare in the Age of Migration" 2011.
Are we ready to make the UK the best country to grow old in?
One year ago, the House of Lords Committee on Public Services and Demographic Change produced a hard-hitting report which argued that the Government and society was “woefully underprepared” for a rapidly ageing population.
On the first anniversary of the ‘Ready for Ageing?’ report, we are in the unenviable position that sees the United Kingdom ranked unlucky number 13 in a global index of the best countries in the world to grow old in. The principal recommendations in the ‘Ready for Ageing?’ report have not yet been properly addressed or acted on.
In his October 2013 speech on ‘The Forgotten Million’, Secretary of State for Health, Jeremy Hunt MP, set down a challenge that the UK should in fact aspire to be best country to grow old in, but the question remains: why are our public services so poorly prepared for major demographic change, and what as a society can we do to ensure future generations of older people thrive in later life?
Lord Filkin, Chair of the Committee on Public Services and Demographic Change, hosted a House of Lords breakfast debate looking forward to 2030, a date by which there will be 50% more people aged 65 and over in England and a doubling in the numbers of people aged 85 and over. As a society, we need to prepare for the next 15 years right now and certainly in the next Parliament.
At this event, Independent Age and ILC-UK, supported by members of the Ready for Ageing Alliance, launched 2030 Vision: Making the UK the best country to grow old in, which will look to the long term and consider what politicians and policy makers need to now, both in preparation for next year’s General Election, and between 2015 and 2020, to prepare for the long term opportunities and challenges ahead.
During the debate, we invited contributions on the economic and societal implications of population ageing and the major policy decisions all the main parties face to ready the UK and its public services for dramatic population ageing.
It’s clear that our political, social and cultural approach towards old age today is already hopelessly out of date, so this event will provide Parliamentarians and stakeholders from across civil society with an opportunity to mark the first anniversary of the House of Lords’ Committee report on demographic change and look ahead, so as a society we can seize the opportunities presented by an ageing population.
Author: Dr Christa Maria Joel
Module: Effects of lifestyle on health
Supervisor: Ms Jane Tobias and Dr Daniel Boakye
University of the West of Scotland
This is part 2 of a two part session deliver for a Common Awards (Theology, Ministry and Mission, University of Durham) course on health and the Church. The first part focuses on a theological perspective and the second part focuses on public health perspectives
David Melzer: Health care quality for an active later lifeThe King's Fund
Dr David Melzer, Professor of Epidemiology and Public Health at the University of Exeter Medical School, spoke at our conference, Making health and care services fit for an ageing population. David analysed the UK's performance in preventing later life disease and disability and considered how well we are delivering treatment for the common disabling diseases of later life.
Presentazione a cura del Dottor Paolo Falaschi - XII° Congresso Nazionale FIMeG 2018 - The Silver Tsunami: l'anziano fra appropriatezza e farmaeconomia
Hue Ump English Club Dec 09 Health OverviewBinhThang
This topic discused at Mortality,Morbidity in the Population and Sudden Infant Death Syndrome by Dr Professor Michael Dunne
QUT School of Public Health
Director, International Health Program.
Similar to Osteoporosis 2016 | Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD: Elizabeth Curtis #osteo2016 (20)
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Osteoporosis 2016 | Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD: Elizabeth Curtis #osteo2016
1. Variation in UK fracture incidence by age, sex,
geography, ethnicity, socioeconomic status
and time: Results from the UK CPRD
Elizabeth M Curtis, Robert van der Velde, Rebecca J Moon, Joop P
W van den Bergh, Piet Geusens, Frank de Vries, Tjeerd P van Staa,
Cyrus Cooper*,Nicholas C Harvey*
*CC and NCH are joint senior author
Presenter Disclosure Information:
This speaker has no conflicts of interest
2. Background
• Economic and personal costs of
osteoporotic fracture
substantial– 37bn Euros, 1.18m
QALYs lost annually1
• Large variability in fracture
incidence worldwide –
differences according to
geography, ethnicity,
socioeconomics2
• Last study in UK published 20013
– current study 1988-20124 1. Hernlund et al, Arch Osteoporos, 8 (2013) 136.
2. Kanis et al, Osteoporos Int. 23 (2012) 2239-2256.
3. Van Staa et al, Bone 29 (2001) 517-522.
4. Curtis EM et al., Bone 87 (2016) 19-26
3. Aim
• To describe the incidence of fracture in the
UK by age, sex, fracture site, geographic
location, socioeconomic status, ethnicity
and calendar time
4. • UK Clinical Practice Research Datalink - anonymised electronic patient
records collected by General Practitioners
• Approximately 6.9% of the UK population, with representative
demographics
• Data stored as READ codes referenced to ICD-9, validated fracture
outcomes4; standardised ethnicity5
• All individuals aged >18 yrs with a fracture recorded on GP records
between 1988-2012 included in analysis
• Incidence calculated (per 10,000 py) by age, sex, fracture site, ethnicity,
socioeconomic status, geographic location, calendar period
https://www.cprd.com/home/
4. Van Staa, Pharmacoepidemiol Drug Saf. 9 (2000) 359-366
5. Mathur et al, J Public Health (Oxf). 36 (2014) 684-692
Methods
5. Age- and sex-specific fracture incidence rate at
any site among UK adults, 1988-2012
0
50
100
150
200
250
300
350
400
450
25 30 35 40 45 50 55 60 65 70 75 80 85 90 90+
Incidence/10,000personyears
Age category
male
female
18-49 years 121219 94.8 78265 54.3
50+ years 75331 71.8 185267 155.4
Curtis EM et al., Bone 87 (2016) 19-26
Total follow-up time:
Men = 23,285,904 py
Women = 26,342,685 py
6. Regional variation in fragility fracture incidence
in men and women aged 50+ years within the UK
Relative rates of fracture are
displayed in comparison to
London
Differences keeping with
patterns of socioeconomic
status, rural population,
possibly ethnicity
differences, falls, vitamin D
deficiency
Fragility fracture: spine,
hip, wrist, rib, pelvis, and
humerus
Curtis EM et al., Bone 87 (2016) 19-26
7. Socioeconomic status and fracture incidence in
UK men and women aged 50+ years
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1 2 3 4 5
Relativerateoffracture
Index of Multiple Deprivation Category
Fragility
Men
Women
IMD 5 = most deprived
Curtis EM et al., Bone 87 (2016) 19-26
RR fracture hip fracture
males category 5= 1.3
Possible causes: smoking,
alcohol, diet, prevalence of
obesity, influence of manual
work may account for sex
differences
8. Incidence of fragility and femur/hip by ethnicity
in UK men and women aged 50+ years
Black 88 15.75 149 22.26
Mixed 22 17.37 77 50.12
South Asian 289 26.85 491 44.46
Other/ unknown 20883 36.19 59824 97.23
White 25285 41.74 71081 104.03
Black 26 4.57 44 6.45
Mixed 4 3.07 14 8.77
South Asian 68 6.15 115 10.03
Other/ unknown 6767 11.13 22390 33.52
White 7901 12.27 24520 32.61
Curtis EM et al., Bone 87 (2016) 19-26
10. Conclusions
• Up to date age- and sex-specific fractures rates for the UK
presented
• Marked variation in rates by geographic location,
socioeconomic status and ethnicity
• Reasons for differences likely multiple (e.g. diet, lifestyle,
adiposity, BMD, bone geometry)
• In contrast to the plateau/decrease in hip fracture rates
previously shown we observed an increasing rate in hip
fractures in men, and vertebral fractures in both men and
women
• Potential implications for healthcare planning in UK and
elsewhere
12. Variation in UK fracture incidence by age, sex,
geography, ethnicity, socioeconomic status
and time: Results from the UK CPRD
Elizabeth M Curtis, Robert van der Velde, Rebecca J Moon, Joop P
W van den Bergh, Piet Geusens, Frank de Vries, Tjeerd P van Staa,
Cyrus Cooper*,Nicholas C Harvey*
*CC and NCH are joint senior author
Presenter Disclosure Information:
This speaker has no conflicts of interest